These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 1438384)

  • 1. Diagnosis of inborn errors of phytanic acid oxidation using tritiated phytanic acid.
    Zenger-Hain J; Craft DA; Rizzo WB
    Prog Clin Biol Res; 1992; 375():399-407. PubMed ID: 1438384
    [No Abstract]   [Full Text] [Related]  

  • 2. Screening for inborn errors of fatty acid oxidation in cultured fibroblasts: an overview.
    Rhead WJ
    Prog Clin Biol Res; 1990; 321():365-82. PubMed ID: 2183237
    [No Abstract]   [Full Text] [Related]  

  • 3. Involvement of both peroxisomes and mitochondria in the alpha-oxidation of phytanic acid.
    Mihalik SJ; Soliman TM; Day RF; Watkins PA
    Prog Clin Biol Res; 1992; 375():239-44. PubMed ID: 1438369
    [No Abstract]   [Full Text] [Related]  

  • 4. Identification of pristanal dehydrogenase activity in peroxisomes: conclusive evidence that the complete phytanic acid alpha-oxidation pathway is localized in peroxisomes.
    Jansen GA; van den Brink DM; Ofman R; Draghici O; Dacremont G; Wanders RJ
    Biochem Biophys Res Commun; 2001 May; 283(3):674-9. PubMed ID: 11341778
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disorders related to the metabolism of phytanic acid.
    Stokke O; Skjeldal OH; Høie K
    Scand J Clin Lab Invest Suppl; 1986; 184():3-10. PubMed ID: 2438746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of glycine oxidation in cultured fibroblasts by isoleucine.
    Hillman RE; Sowers LH; Cohen JL
    Pediatr Res; 1973 Dec; 7(12):945-7. PubMed ID: 4753048
    [No Abstract]   [Full Text] [Related]  

  • 7. Peroxisomes, Refsum's disease and the alpha- and omega-oxidation of phytanic acid.
    Wanders RJ; Komen JC
    Biochem Soc Trans; 2007 Nov; 35(Pt 5):865-9. PubMed ID: 17956234
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oxidation of pristanic acid in fibroblasts and its application to the diagnosis of peroxisomal beta-oxidation defects.
    Paton BC; Sharp PC; Crane DI; Poulos A
    J Clin Invest; 1996 Feb; 97(3):681-8. PubMed ID: 8609223
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atypical refsum disease with pipecolic acidemia and abnormal catalase distribution.
    Baumgartner MR; Jansen GA; Verhoeven NM; Mooyer PA; Jakobs C; Roels F; Espeel M; Fourmaintraux A; Bellet H; Wanders RJ; Saudubray JM
    Ann Neurol; 2000 Jan; 47(1):109-13. PubMed ID: 10632109
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CYP4 isoform specificity in the omega-hydroxylation of phytanic acid, a potential route to elimination of the causative agent of Refsum's disease.
    Xu F; Ng VY; Kroetz DL; de Montellano PR
    J Pharmacol Exp Ther; 2006 Aug; 318(2):835-9. PubMed ID: 16707724
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies on phytanic acid alpha-oxidation in rat liver and cultured human skin fibroblasts.
    Wanders RJ; Van Roermund CW
    Biochim Biophys Acta; 1993 Apr; 1167(3):345-50. PubMed ID: 8386940
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Accumulation of phytanic acid alpha-oxidation intermediates in Zellweger fibroblasts.
    Fingerhut R; Schmitz W; Conzelmann E
    J Inherit Metab Dis; 1993; 16(3):591-4. PubMed ID: 7541878
    [No Abstract]   [Full Text] [Related]  

  • 13. Characterization of phytanic acid omega-hydroxylation in human liver microsomes.
    Komen JC; Duran M; Wanders RJ
    Mol Genet Metab; 2005 Jul; 85(3):190-5. PubMed ID: 15979030
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnosis of peroxisomal disorders with neurological involvement.
    Molzer B
    Padiatr Padol; 1993; 28(1):43-8. PubMed ID: 8446428
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resolution of the phytanic acid alpha-oxidation pathway: identification of pristanal as product of the decarboxylation of 2-hydroxyphytanoyl-CoA.
    Verhoeven NM; Schor DS; ten Brink HJ; Wanders RJ; Jakobs C
    Biochem Biophys Res Commun; 1997 Aug; 237(1):33-6. PubMed ID: 9266824
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lethal neonatal deficiency of carbamyl phosphate synthetase.
    Gelehrter TD; Snodgrass PJ
    N Engl J Med; 1974 Feb; 290(8):430-3. PubMed ID: 4811018
    [No Abstract]   [Full Text] [Related]  

  • 17. Multiple acyl-coenzyme A dehydrogenation disorders (MAD) responsive to riboflavin: biochemical studies in fibroblasts.
    Roettger V; Marshall T; Amendt B; Rhead WJ
    Prog Clin Biol Res; 1992; 375():317-26. PubMed ID: 1438377
    [No Abstract]   [Full Text] [Related]  

  • 18. Phytanoyl-CoA hydroxylase is present in human liver, located in peroxisomes, and deficient in Zellweger syndrome: direct, unequivocal evidence for the new, revised pathway of phytanic acid alpha-oxidation in humans.
    Jansen GA; Mihalik SJ; Watkins PA; Moser HW; Jakobs C; Denis S; Wanders RJ
    Biochem Biophys Res Commun; 1996 Dec; 229(1):205-10. PubMed ID: 8954107
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impaired degradation of phytanic acid in cells from patients with mitochondriopathies: evidence for the involvement of ETF and the respiratory chain in phytanic acid alpha-oxidation.
    Fingerhut R; Schmitz W; Garavaglia B; Reichmann H; Conzelmann E
    J Inherit Metab Dis; 1994; 17(5):527-32. PubMed ID: 7837758
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peroxisomal disorders affecting phytanic acid alpha-oxidation: a review.
    Wierzbicki AS
    Biochem Soc Trans; 2007 Nov; 35(Pt 5):881-6. PubMed ID: 17956237
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.